$ALXN Form 8-K

0
634
Biotech Stocks

Form 8-K for ALEXION PHARMACEUTICALS INC


26-Mar-2015

Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.On March 21, 2015, Mr. William Keller informed the Board of Directors of Alexion Pharmaceuticals, Inc. of his decision to retire from the Board and not stand for re-election at the 2015 Annual Meeting of Shareholders to be held on May 6, 2015. Mr. Keller, a director since 2009, will continue to serve as a director until the 2015 Annual Meeting.

Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 26, 2015 ALEXION PHARMACEUTICALS, INC.

By: /s/ Michael V. Greco
Name: Michael V. Greco
Title: Vice President of Law and Corporate Secretary
  Add ALXN to Portfolio     Set Alert         Email to a Friend
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ALXN All Recent SEC Filings

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here